Northpond Ventures II GP, LLC - 15 Oct 2024 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)

Role: 10%+ Owner
Signature: Northpond Ventures II GP, LLC, By: /s/ Patrick Smerkers, Authorized Signatory
Issuer symbol: CAMP
Transactions as of: 15 Oct 2024
Net transactions value: +$8,399,996
Form type: 4
Filing time: 17 Oct 2024, 18:34:47 UTC
Previous filing: 10 Oct 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CAMP	Common Stock	Conversion of derivative security		+1,003,193			1,003,193	15 Oct 2024	By Northpond Ventures II, LP	F1, F2
transaction	CAMP	Common Stock	Conversion of derivative security		+471,415			471,415	15 Oct 2024	By Northpond Ventures, LP	F1, F3
transaction	CAMP	Common Stock	Purchase	$8,399,996	+763,636		$11.00	763,636	15 Oct 2024	By Northpond Ventures III, LP	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CAMP	Series A Prime Preferred Stock	Conversion of derivative security		-11,251,624	-100%		0	15 Oct 2024	Common Stock	1,003,193		By Northpond Ventures II, LP	F1, F2
transaction	CAMP	Series B Preferred Stock	Conversion of derivative security		-5,287,303	-100%		0	15 Oct 2024	Common Stock	471,415		By Northpond Ventures, LP	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series A Prime Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 11.2158-for-one basis without payment of further consideration. Immediately prior to the closing of the Issuer's initial public offering, the Preferred Stock was converted into the number of shares of Common Stock of the Issuer shown in column 7 of Table II. The Preferred Stock had no expiration date.
F2	The shares are held directly by Northpond Ventures II, LP ("Northpond Fund II"). Northpond Ventures II GP, LLC ("Northpond II GP") is the general partner of Northpond Fund II, and Michael P. Rubin is the managing member of Northpond II GP. As a result, each of Northpond II GP and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond II GP and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
F3	The shares are held directly by Northpond Ventures, LP ("Northpond Fund I"). Northpond Ventures GP, LLC ("Northpond GP I") is the general partner of Northpond Fund I, and Michael P. Rubin is the managing member of Northpond GP I. As a result, each of Northpond GP I and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund I. Each of Northpond GP I and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
F4	The shares are held directly by Northpond Ventures III, LP ("Northpond Fund III"). Northpond Ventures III GP, LLC ("Northpond III GP") is the general partner of Northpond Fund III, and Michael P. Rubin is the managing member of Northpond III GP. As a result, each of Northpond III GP and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund III. Each of Northpond III GP and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.